A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19)

Phase 4

Not yet recruiting

• Conditions: novel coronavirus pneumonia (COVID-19)

• Registration Number: ITMCTR2000002954
• Lead Sponsor: Beijing hospital of Traditional Chinese medicine; Hubei integrated traditional Chinese and Western Medicine Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Pneumonia patients diagnosed as new coronavirus infection;
2) The type of pneumonia was judged as severe and critical;
3) Informed consent.

Exclusion Criteria

1) patients were judged not suitable to participate in the study;
2) patients were not suitable to use Chinese patent medicine.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mechanical ventilation time;Length of stay in hospital;PSI score;CURB-65;

Secondary Outcome Measures

Name	Time	Method
Antipyretic time;Time of virus turning negative;Pulmonary function;mortality and recovery rate;Adverse events;rate of multiple organ dysfunction;Inflammation index;